We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > endurance

News List

Fortacin™ Receives Extremely Encouraging Assessment in US Market Research Analysis prnasia
July 29, 2021
Endurance RP Limited is pleased to announce that Fortacin™, a European, China ( Hong Kong, S.A.R., China and Macau, S.A.R., China ) approved treatment for PE receives a detailed market assessment by MME, one of the leading global market research companies
Deep Longevity Repurposes a Blood Aging Clock for Saliva Samples prnasia
July 28, 2021
Endurance RP Limited's wholly owned subsidiary Deep Longevity, Inc, a leading provider of deep biomarkers of aging and longevity is pleased to announce the publication of its Frontiers in Aging article "Adapting blood DNAm aging clocks for use in ...
Fortacin™ Receives Strong Positive Results for US Phase II PRO Validation Study prnasia
July 16, 2021
Endurance RP Limited is pleased to announce the successful completion of prespecified data analysis from the United States study mandated patient reported outcome for PE.
Human Endurance May Have Its Limits: Study drugs
June 06, 2019
Human Endurance May Have Its Limits.